Status:
COMPLETED
D-dimer Assay for the Exclusion of Intra-atrial Thrombus Risk Before Ablation of Atrial Fibrillation
Lead Sponsor:
Groupe Hospitalier de la Rochelle Ré Aunis
Collaborating Sponsors:
Medtronic
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether D-dimer dosage allow to exclude risk of intraatrial thrombus before performing an ablation of atrial fibrillation
Eligibility Criteria
Inclusion
- Age\> 18 years.
- Patients hospitalized for ablation of atrial fibrillation or symptomatic left flutter
- Patient informed of the study
Exclusion
- Age \<18 years.
- Patients under guardianship
- Pregnant woman
- Contraindication to transesophageal echocardiography
- transesophageal echocardiography made in another center as the center of ablation
- Refusal of the patient to participate in the study
- Patient participating in another interventional study in which an intervention related to biomedical research is performed before the transesophageal echocardiography
Key Trial Info
Start Date :
July 28 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
2506 Patients enrolled
Trial Details
Trial ID
NCT02199080
Start Date
July 28 2014
End Date
May 1 2016
Last Update
October 30 2023
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de cardiologie, CH de la Région d'Annecy
Annecy, France
2
Centre Hospitalier d' Auxerre
Auxerre, France
3
Service de cardiologie, CH Avignon
Avignon, France
4
Clinique La Fourcade
Bayonne, France